Adenomas Global Clinical Trials Review, H1, 2012

  • May 2012
  • -
  • Global Data
  • -
  • 99 pages

Adenomas Global Clinical Trials Review, H1, 2012



Summary



GlobalData's clinical trial report, “Adenomas Global Clinical Trials Review, H1, 2012" provides data on the Adenomas clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Adenomas. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Adenomas. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Adenomas 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Adenomas 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Adenomas Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Bristol-Myers Squibb Company 33
Clinical Trial Overview of Bristol-Myers Squibb Company 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Agouron Pharmaceuticals Inc. 35
Clinical Trial Overview of Agouron Pharmaceuticals Inc. 35
Nihon Pharmaceutical Industry Co., Ltd. 36
Clinical Trial Overview of Nihon Pharmaceutical Industry Co., Ltd. 36
BTG plc 37
Clinical Trial Overview of BTG plc 37
ArQule, Inc. 38
Clinical Trial Overview of ArQule, Inc. 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
ImClone LLC 40
Clinical Trial Overview of ImClone LLC 40
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
GlaxoSmithKline plc 42
Clinical Trial Overview of GlaxoSmithKline plc 42
Amgen Inc. 43
Clinical Trial Overview of Amgen Inc. 43
Clinical Trial Overview of Top Universities / Institutes / Hospitals 44
Mayo Clinic 44
Clinical Trial Overview of Mayo Clinic 44
Fourth Military Medical University 45
Clinical Trial Overview of Fourth Military Medical University 45
Assistance Publique - Hopitaux de Paris 46
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 46
Memorial Sloan Kettering Cancer Center 47
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 47
Mid-Atlantic Oncology Program 48
Clinical Trial Overview of Mid-Atlantic Oncology Program 48
Stanford University 49
Clinical Trial Overview of Stanford University 49
H. Lee Moffitt Cancer Center and Research Institute 50
Clinical Trial Overview of H. Lee Moffitt Cancer Center and Research Institute 50
University of California, Irvine 51
Clinical Trial Overview of University of California, Irvine 51
National Taiwan University Hospital 52
Clinical Trial Overview of National Taiwan University Hospital 52
Vanderbilt-Ingram Cancer Center 53
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 53
Dartmouth-Hitchcock Medical Center 54
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 54
Cancer Prevention Institute of California 55
Clinical Trial Overview of Cancer Prevention Institute of California 55
Huashan Hospital 56
Clinical Trial Overview of Huashan Hospital 56
University of Pittsburgh 57
Clinical Trial Overview of University of Pittsburgh 57
The University of Texas M. D. Anderson Cancer Center 58
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 58
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 59
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 59
Nantes University Hospital 60
Clinical Trial Overview of Nantes University Hospital 60
Universitaire Ziekenhuizen Leuven 61
Clinical Trial Overview of Universitaire Ziekenhuizen Leuven 61
Federal University of Sao Paulo 62
Clinical Trial Overview of Federal University of Sao Paulo 62
Cedars-Sinai Medical Center 63
Clinical Trial Overview of Cedars-Sinai Medical Center 63
Five Key Clinical Profiles 64
Appendix 96
Abbreviations 96
Definitions 96
Research Methodology 97
Secondary Research 97
About GlobalData 98
Contact Us 98
Disclaimer 98
Source 99
List of Tables

List of Tables
Adenomas Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Adenomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Adenomas Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14
Adenomas Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Adenomas Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Adenomas Therapeutics Clinical Trials, G7 Countries, 2012* 17
Adenomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Adenomas Therapeutics Clinical Trials, E7 Countries, 2012* 19
Adenomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Adenomas Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Adenomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Adenomas Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Adenomas Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Adenomas Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Adenomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 33
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Agouron Pharmaceuticals Inc., 2012* 35
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Nihon Pharmaceutical Industry Co., Ltd., 2012* 36
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by BTG plc, 2012* 37
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012* 38
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 39
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012* 40
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 41
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 42
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 43
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 44
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Fourth Military Medical University, 2012* 45
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 46
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 47
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Mid-Atlantic Oncology Program, 2012* 48
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 49
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center and Research Institute, 2012* 50
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012* 51
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 52
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 53
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2012* 54
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Prevention Institute of California, 2012* 55
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2012* 56
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 57
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 58
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2012* 59
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Nantes University Hospital, 2012* 60
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2012* 61
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 62
Adenomas Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2012* 63
List of Figures

List of Figures
Adenomas Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Adenomas Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Adenomas Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Adenomas Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Adenomas Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Adenomas Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14
Adenomas Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Adenomas Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Adenomas Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Adenomas Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Adenomas Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Adenomas Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Adenomas Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Adenomas Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Adenomas Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Adenomas Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Adenomas Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Adenomas Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Adenomas Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 97

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Global Proteomics Market

Global Proteomics Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of ...

Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 201

Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 201

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

Label-free technology is rapidly gaining widespread acceptance as a drug discovery and life science research tool. Currently, the drug discovery process is based on target identification and screening ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.